279 related articles for article (PubMed ID: 21674174)
21. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
Li M; Zhao ZW
Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
[TBL] [Abstract][Full Text] [Related]
22. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.
Michailidi C; Theocharis S; Tsourouflis G; Pletsa V; Kouraklis G; Patsouris E; Papavassiliou AG; Troungos C
Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636
[TBL] [Abstract][Full Text] [Related]
23. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
25. Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers.
Wu F; Liu J; Qiu YL; Wang W; Zhu SM; Sun P; Miao WB; Li YL; Brandt-Rauf PW; Xia ZL
Int J Occup Med Environ Health; 2013 Mar; 26(1):173-82. PubMed ID: 23412991
[TBL] [Abstract][Full Text] [Related]
26. Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Baba H
Surg Today; 2013 Dec; 43(12):1355-64. PubMed ID: 23291904
[TBL] [Abstract][Full Text] [Related]
27. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
[TBL] [Abstract][Full Text] [Related]
28. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
31. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
[TBL] [Abstract][Full Text] [Related]
32. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma.
Lu C; Xie H; Wang F; Shen H; Wang J
BMC Cancer; 2011 Mar; 11():91. PubMed ID: 21375764
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
34. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
35. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
36. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
Alvarez MC; Santos JC; Maniezzo N; Ladeira MS; da Silva AL; Scaletsky IC; Pedrazzoli J; Ribeiro ML
World J Gastroenterol; 2013 May; 19(20):3043-51. PubMed ID: 23716983
[TBL] [Abstract][Full Text] [Related]
37. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
38. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
[TBL] [Abstract][Full Text] [Related]
39. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
[TBL] [Abstract][Full Text] [Related]
40. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.
Malhotra P; Anwar M; Kochhar R; Ahmad S; Vaiphei K; Mahmood S
Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
